SG/CALL/DERMAPHARM HOLDING/44/0.1/20.06.25 Stock

Warrant

DE000SY0D864

Real-time Boerse Frankfurt Warrants 07:13:27 2024-07-08 EDT
0.27 EUR 0.00% Intraday chart for SG/CALL/DERMAPHARM HOLDING/44/0.1/20.06.25
Current month+17.39%
1 month-10.00%
Date Price Change
24-07-08 0.27 0.00%
24-07-05 0.27 +8.00%
24-07-04 0.25 +4.17%
24-07-03 0.24 +4.35%
24-07-02 0.23 0.00%

Real-time Boerse Frankfurt Warrants

Last update July 08, 2024 at 07:13 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying DERMAPHARM HOLDING SE
IssuerLogo Issuer Société Générale Société Générale
WKN SY0D86
ISINDE000SY0D864
Date issued 2024-05-16
Strike 44
Maturity 2025-06-20 (347 Days)
Parity 10 : 1
Emission price 0.25
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.32
Lowest since issue 0.19
Delta0.39x
Omega 5.174
Premium26.83x
Gearing13.18x
Moneyness 0.8386
Difference Strike 7.075
Difference Strike %+16.08%
Spread 0.02
Spread %6.90%
Theoretical value 0.2800
Implied Volatility 33.40 %
Total Loss Probability 72.51 %
Intrinsic value 0.000000
Present value 0.2800
Break even 46.80 €
Theta-0.01x
Vega0.01x
Rho0.01x

Company Profile

Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
Sector
-
More about the company

Ratings for Dermapharm Holding SE

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Dermapharm Holding SE

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
37.1 EUR
Average target price
50.12 EUR
Spread / Average Target
+35.11%
Consensus